Back to results
US 2022/0388955 A1Published application
Ep2 antagonist
AssigneeOno Pharmaceutical Co., Ltd.
InventorsAkio WATANABE, Atsushi YOSHIDA, Yasuo HIROOKA, Michael G. YANG, Ning LI
Life of this patent
Estimating the term…
Abstract
A drug containing, as an active ingredient, a compound having an antagonistic activity against an EP2 receptor in the prevention and/or treatment of a disease associated with the activation of an EP2 receptor, of formula (I-A): wherein all symbols have the same meanings as those described in the specification, or a pharmaceutically acceptable salt thereof.
Claims19
A compound of formula (I-A):
- wherein:
- L1 represents —(CR38R39)—(CR4OR41)—;
- R38, R39, R40 and R41 each independently represent (1) a hydrogen atom, (2) a halogen atom, or (3) a C1-4 alkyl group;
- the C1-4 alkyl group in each of R38, R39, R40 and R41 may be independently substituted by a halogen atom;
- when each of two substituents selected from R38, R39, R40 and R41 is a C1-4 alkyl group, the two substituents may form a C3-6 saturated carbocyclic ring in conjunction with a carbon atom to which the substituents bind;
- L2 represents (1) a bond, (2) a C1-8 alkylene group, (3) a C2-8 alkenylene group, or (4) a C2-8 alkynylene group, wherein one or two carbon atoms in the C1-8 alkylene group, the C2-8 alkenylene group and the C2-8 alkynylene group may be independently replaced by an oxygen atom or a sulfur atom that may be oxidized, and each of the C1-8 alkylene group, the C2-8 alkenylene group and the C2-8 alkynylene group may be substituted by 1 to 8 halogen atoms;
- Y represents (1) a bond, (2) an oxygen atom, or (3) a sulfur atom that may be oxidized;
- R1 represents (1) COOR10, (2) SO3H, (3) SO2NHR11, (4) CONHSO2R12, (5) SO2NHCOR13, (6) CONR14R15, (7) a tetrazolyl group, or (8) a hydroxamic acid;
- R10, R11, R12, R13, R14 and R15 each independently represent (1) a hydrogen atom or (2) a C1-4 alkyl group;
- R2 represents (1) a hydrogen atom or (2) a C1-4 alkyl group;
- R3 represents (1) a halogen atom, (2) a C1-6 alkyl group, (3) a C2-6 alkenyl group, (4) a C2-6 alkynyl group, (5) a C1-6 alkoxy group, (6) a 3- to 6-membered cyclic group, (7) a (3- to 6-membered cyclic group)-O—, or (8) a (3- to 6-membered cyclic group)-(C1-4 alkylene)-;
- each of the groups (2) to (8) in R3 may be substituted by 1 to 9 R16s;
- when there are a plurality of R3s, the plurality of R3s may be the same as or different from each other;
- R16 represents (1) a halogen atom, (2) a C1-4 alkyl group, (3) a C1-4 alkoxy group, (4) a C2-6 acyl group, (5) a C3-6 cycloalkyl group, (6) a hydroxyl group, or (7) —NR17R18;
- when there are a plurality of R16s, the plurality of R16s may be the same as or different from each other;
- R17 and R18 each independently represent (1) a hydrogen atom or (2) a C1-4 alkyl group;
- R4 represents (1) a halogen atom, (2) a C1-6 alkyl group, (3) a C2-6 alkenyl group, (4) a C2-6 alkynyl group, (5) a C1-6 alkoxy group, (6) a 3- to 6-membered cyclic group, (7) (3- to 6-membered cyclic group)-O—, or (8) (3- to 6-membered cyclic group)-(C1-4 alkylene)-;
- each of the groups (2) to (8) in R4 may be substituted by 1 to 9 R19s;
- when there are a plurality of R4s, the plurality of R4s may be the same as or different from each other;
- R19 represents (1) a halogen atom, (2) a C1-4 alkyl group, (3) a C1-4 alkoxy group, (4) a C2-6 acyl group, (5) a C3-6 cycloalkyl group, (6) a hydroxyl group, or (7) —NR20R21;
- R20 and R21 each independently represent (1) a hydrogen atom or (2) a C1-4 alkyl group;
- when there are a plurality of R19s, the plurality of R19s may be the same as or different from each other;
- R5 represents (1) a hydrogen atom, (2) a C3-10 carbocyclic ring, or (3) a 3- to 10-membered heterocyclic ring, wherein each of the C3-10 carbocyclic ring and the 3- to 10-membered heterocyclic ring may be substituted by 1 to 5 R22s;
- when L2 represents a bond, R5 is not a hydrogen atom;
- R22 represents (1) a C1-6 alkyl group, (2) a C2-6 alkenyl group, (3) a C2-6 alkynyl group, (4) a C3-6 cycloalkyl group, (5) a C1-6 alkoxy group, (6) a C3-6 cycloalkyloxy group, (7) a C2-6 acyl group, (8) a C2-6 acyloxy group, (9) a C1-6 alkylthio group, (10) a C3-6 cycloalkylthio group, (11) a C1-6 alkylsulfinyl group, (12) a C3-6 cycloalkylsulfinyl group, (13) a C1-6 alkylsulfonyl group, (14) a C3-6 cycloalkylsulfonyl group, (15) a C1-6 alkoxycarbonyl group, (16) a 5- to 6-membered cyclic group, (17) (5- to 6-membered cyclic group)-(C1-4 alkylene)-, (18) a (5- to 6-membered cyclic group)-(C1-4 alkylene)-O— group, (19) a (5- to 6-membered cyclic group)-C1-4 acyl group, (20) a halogen atom, (21) a hydroxyl group, (22) a nitro group, (23) a cyano group, (24) —NR23R24, (25) —CONR25R26 or (26) —SO2NR27R28;
- R23, R24, R25, R26, R27 and R28 each independently represent (1) a hydrogen atom, (2) a C1-6 alkyl group, (3) a C2-6 acyl group or (4) a C1-6 alkylsulfonyl group;
- each of the groups (1) to (19) in R22 may be substituted by 1 to 9 R29s;
- when there are a plurality of R22s, the plurality of R22s may be the same as or different from each other;
- R29 represents (1) a C1-4 alkyl group, (2) a C1-4 alkoxy group, (3) a C2-6 acyl group, (4) a C3-6 cycloalkyl group, (5) a hydroxyl group, (6) —NR30R31 or (7) a halogen atom;
- R30 and R31 each independently represent (1) a hydrogen atom or (2) a C1-4 alkyl group;
- when there are a plurality of R29s, the plurality of R29s may be the same as or different from each other;
- Q represents (1) an oxygen atom or (2) a sulfur atom;
- X represents (1) CR6 or (2) NR7;
- R6 represents (1) a halogen atom, (2) a C1-6 alkyl group, (3) a C2-6 alkenyl group, (4) a C2-6 alkynyl group, (5) a C1-6 alkoxy group, (6) a 3- to 6-membered cyclic group, (7) (3- to 6-membered cyclic group)-O—, or (8) (3- to 6-membered cyclic group)-(C1-4 alkylene)-;
- each of the groups (2) to (8) in R6 may be substituted by 1 to 9 R32s;
- R32 represents (1) a halogen atom, (2) a C1-4 alkyl group, (3) a C1-4 alkoxy group, (4) a C2-6 acyl group, (5) a C3-6 cycloalkyl group, (6) a hydroxyl group, or (7) —NR33R34;
- R33 and R34 each independently represent (1) a hydrogen atom or (2) a C1-4 alkyl group;
- when there are a plurality of R32s, the plurality of R32s may be the same as or different from each other;
- R7 represents (1) a C1-6 alkyl group, (2) a C2-6 alkenyl group, (3) a C2-6 alkynyl group, (4) a 3- to 6-membered cyclic group, or (5) (3- to 6-membered cyclic group)-(C1-4 alkylene)-;
- R7 may be substituted by 1 to 9 R35s;
- R35 represents (1) a halogen atom, (2) a C1-4 alkyl group, (3) a C1-4 alkoxy group, (4) a C2-6 acyl group, (5) a C3-6 cycloalkyl group, (6) a hydroxyl group, or (7) —NR36R37;
- R36 and R37 each independently represent (1) a hydrogen atom or (2) a C1-4 alkyl group;
- when there are a plurality of R35s, the plurality of R35s may be the same as or different from each other;
- the ring A represents (1) a benzene ring, or (2) a 5- to 6-membered nitrogen-containing aromatic heterocyclic ring;
- the symbol
- in the ring A represents a single bond or a double bond;
- n represents an integer of 1 to 4;
- and
- m represents an integer of 0 to 3,
- provided that 3-[3-[(2,6-dimethoxybenzoyl)amino]-4-propoxyphenyl]propanoic acid,
- methyl 3-[5-({[1-tert-butyl-5-(4-fluorophenyl-1H-pyrazol-4-yl]carbonyl}amino-2-chlorophenyl]propanoate,
- 3-[5-({[1-tert-butyl-5-(4-fluorophenyl-1H-pyrazol-4-yl]carbonyl}amino-2-chlorophenyl]propanoic acid,
- α-ethyl-3-[N-(1′-phenyl-5′-methyl-1′,2′,3′-triazolecarbonyl)]amino-2,4,6-triiodohydrocinnamic acid, and
- α-ethyl-3-{N-(1′-(4″-iodophenyl)-5′-methyl-1,2,3-triazolecarbonyl]}amino-2,4,6-triiodohydrocinnamic acid are excluded;
- or a pharmaceutically acceptable salt thereof.
52 more elements
(canceled)
Dependencies are inferred from the claim text.